AbCellera

is a Canada-based biotechnology company that researches and develops antibody therapeutics for the treatment of viral infections...
Read more
AbCellera CEO: Carl Hansen

CEO

Carl Hansen

CEO Approval Rating

90/100

2012

PublicIndependent CompanyNASDAQABCL

8000 NAICS listing
Annual Revenue
$28.8M
Employees
596
Funding
$1.4B
Acquisitions
4
Investments
1

AbCellera Competitors

1PhenomeX
2HiFiBiO
3Ligand
4Sphere Fluidics
5Kymab
6XBiotech
7Alder BioPharmaceuticals
8XOMA Royalty
9Igenica
10SCT
See 18+ competitors

Trending Companies